MA41666A1 - Anti-ox40 antibodies and their uses - Google Patents

Anti-ox40 antibodies and their uses

Info

Publication number
MA41666A1
MA41666A1 MA41666A MA41666A MA41666A1 MA 41666 A1 MA41666 A1 MA 41666A1 MA 41666 A MA41666 A MA 41666A MA 41666 A MA41666 A MA 41666A MA 41666 A1 MA41666 A1 MA 41666A1
Authority
MA
Morocco
Prior art keywords
antibodies
heavy
light chain
chain variable
variable region
Prior art date
Application number
MA41666A
Other languages
French (fr)
Other versions
MA41666B1 (en
Inventor
Zhehong Cai
Indrani Chakraborty
Marie-Michelle Garcia
Thomas Kempe
Alexander Kozhich
Hadia LEMAR
Mark Maurer
Christina Milburn
Michael Quigley
Maria Rodriguez
Xiang Shao
Mohan Srinivasan
Brenda Stevens
Kent Thudium
Susan Wong
Jochem Gokemeijer
xi-tao Wang
Han Chang
Christine Huang
Maria Jure-Kunkel
Zheng Yang
Yan Feng
Patrick Guirnalda
Nils Lonberg
Aaron P Yamniuk
Michelle Minhua Han
Ming Lei
Liang Schweizer
Sandra V Hatcher
Alan Korman
Bryan C Barnhat
Karla A Henning
Arvind Rajpal
Praveen Aanur
Mark J Selby
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority claimed from PCT/US2016/034470 external-priority patent/WO2016196228A1/en
Publication of MA41666A1 publication Critical patent/MA41666A1/en
Publication of MA41666B1 publication Critical patent/MA41666B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des anticorps ou des parties de liaison à l'antigène de ceux-ci, qui se lient à ox40. L'invention concerne également des utilisations de ces protéines dans des applications thérapeutiques, telles que dans le traitement du cancer. En outre, l'invention concerne des cellules qui produisent lesdits anticorps, des polynucléotides codant pour la région variable de chaîne lourde et/ou légère desdits anticorps ainsi que des vecteurs comprenant les polynucléotides codant pour la région variable de chaîne lourde et/ou légère desdits anticorps.The invention provides antibodies or antigen-binding portions thereof that bind to ox40. The invention also relates to uses of these proteins in therapeutic applications, such as in the treatment of cancer. In addition, the invention provides cells which produce said antibodies, polynucleotides encoding the heavy and / or light chain variable region of said antibodies as well as vectors comprising polynucleotides encoding the heavy and / or light chain variable region of said antibody.

MA41666A 2015-05-29 2016-05-26 Anti-ox40 antibodies and their uses MA41666B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562168377P 2015-05-29 2015-05-29
PCT/US2016/034470 WO2016196228A1 (en) 2015-05-29 2016-05-26 Antibodies against ox40 and uses thereof

Publications (2)

Publication Number Publication Date
MA41666A1 true MA41666A1 (en) 2018-07-31
MA41666B1 MA41666B1 (en) 2020-10-28

Family

ID=59981546

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41666A MA41666B1 (en) 2015-05-29 2016-05-26 Anti-ox40 antibodies and their uses

Country Status (2)

Country Link
AR (1) AR105230A1 (en)
MA (1) MA41666B1 (en)

Also Published As

Publication number Publication date
AR105230A1 (en) 2017-09-20
MA41666B1 (en) 2020-10-28

Similar Documents

Publication Publication Date Title
MA42622B1 (en) LIAISONS IN TIGIT AND THEIR USES
MA45029A (en) ANTI-PD-1 AND ANTI-LAG3 ANTIBODIES FOR CANCER TREATMENT
EA202090104A1 (en) ANTIBODY MOLECULES TO CD73 AND WAYS OF THEIR APPLICATION
MA45712A (en) ANTI-GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND TO GPRC5D AND CD3 AND THEIR USES
MY200602A (en) Antibodies against tim3 and uses thereof
MA49599B1 (en) Antibodies specific to cd47 and pd-l1
MA40609B1 (en) Cd123 binding agents and their uses
MA46708B1 (en) Anti-pd1 antibodies and their uses
MA40476A (en) ANTIBODIES AND FRAGMENTS OF BINDING WITH ANTI-LAG3 ANTIGEN
MA46619B1 (en) Anti-il-33 antibodies and their uses
EA201890145A1 (en) ANTIBODIES TO FACTOR XI AND METHODS OF THEIR APPLICATION
EA201792221A1 (en) ANTIBODIES AGAINST SORTILINE AND METHODS OF THEIR APPLICATION
TN2019000101A1 (en) Antibodies against ox40 and uses thereof.
MX2022010487A (en) Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof.
MA45125B1 (en) Anti-alpha-synuclein antibodies and their uses
NZ739028A (en) Humanized or chimeric cd3 antibodies
MA47221A1 (en) Monoclonal antibody to pd-l1
MD20140108A2 (en) Antibodies to matrix metalloproteinase 9
MD20140107A2 (en) Antibodies to matrix metalloproteinase 9
MX2022009915A (en) Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof.
MA38161A1 (en) Anti-bmp-6 Antibody
EA202092085A1 (en) THERAPEUTIC ANTIBODIES AGAINST sPLA2-GIB AND THEIR APPLICATION
EA202190235A1 (en) ANTIBODIES TO CD33 AND METHODS OF THEIR APPLICATION
EA201990978A1 (en) ANTIBODIES AGAINST PD-1
EA202190954A1 (en) HUMANIZED MONOCLONAL ANTIBODY AGAINST N-TRUNCTIONED BETA-AMYLOID